1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > AIDS - Related Kaposi's Sarcoma - Pipeline Review, H1 2014

AIDS - Related Kaposi's Sarcoma - Pipeline Review, H1 2014

  • January 2014
  • -
  • Global Markets Direct
  • -
  • 53 pages

AIDS - Related Kaposi's Sarcoma - Pipeline Review, H1 2014

Summary

Global Markets Direct’s, 'AIDS - Related Kaposi's Sarcoma - Pipeline Review, H1 2014', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for AIDS - Related Kaposi's Sarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for AIDS - Related Kaposi's Sarcoma. AIDS - Related Kaposi's Sarcoma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for AIDS - Related Kaposi's Sarcoma.
- A review of the AIDS - Related Kaposi's Sarcoma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the AIDS - Related Kaposi's Sarcoma pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for AIDS - Related Kaposi's Sarcoma.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding AIDS - Related Kaposi's Sarcoma pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Table Of Contents

AIDS - Related Kaposi's Sarcoma - Pipeline Review, H1 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
AIDS - Related Kaposi's Sarcoma Overview 6
Therapeutics Development 7
Pipeline Products for AIDS - Related Kaposi's Sarcoma - Overview 7
Pipeline Products for AIDS - Related Kaposi's Sarcoma - Comparative Analysis 8
AIDS - Related Kaposi's Sarcoma - Therapeutics under Development by Companies 9
AIDS - Related Kaposi's Sarcoma - Pipeline Products Glance 10
Clinical Stage Products 10
Early Stage Products 11
AIDS - Related Kaposi's Sarcoma - Products under Development by Companies 12
AIDS - Related Kaposi's Sarcoma - Companies Involved in Therapeutics Development 13
Aphios Corporation 13
CytRx Corporation 14
Cannabis Science, Inc. 15
Xiamen Amoytop Biotech Co., Ltd. 16
Biogenomics 17
AIDS - Related Kaposi's Sarcoma - Therapeutics Assessment 18
Assessment by Monotherapy Products 18
Assessment by Target 19
Assessment by Mechanism of Action 21
Assessment by Route of Administration 23
Assessment by Molecule Type 25
Assessment by Therapeutic Class 27
Drug Profiles 29
aldoxorubicin - Drug Profile 29
Product Description 29
Mechanism of Action 29
RandD Progress 29
paclitaxel nanosomal - Drug Profile 31
Product Description 31
Mechanism of Action 31
RandD Progress 31
CS-TATI-1 - Drug Profile 32
Product Description 32
Mechanism of Action 32
RandD Progress 32
interferon alfa-2a biosimilar - Drug Profile 33
Product Description 33
Mechanism of Action 33
RandD Progress 33
interferon alfa-2b - Drug Profile 34
Product Description 34
Mechanism of Action 34
RandD Progress 34
interferon alfa-2a - Drug Profile 35
Product Description 35
Mechanism of Action 35
RandD Progress 35
AIDS - Related Kaposi's Sarcoma - Recent Pipeline Updates 36
AIDS - Related Kaposi's Sarcoma - Dormant Projects 46
AIDS - Related Kaposi's Sarcoma - Discontinued Products 47
AIDS - Related Kaposi's Sarcoma - Product Development Milestones 48
Featured News and Press Releases 48
Oct 08, 2012: JandJ Files Applications Seeking US And EU Approvals For New Manufacturing Process Of Doxil 48
Oct 25, 2006: Eisai Announces Completion of Acquisition of Four Oncology-Related Products from Ligand 48
Sep 07, 2006: Eisai Acquires Four Oncology-Related Products from Ligand 48
Feb 07, 2005: U.S. FDA grants full approval to DOXIL following submission of Phase III data 49
Jul 17, 2000: European CPMP Recommendes the approval of Ligand's Panretin Gel 49
Jan 06, 2000: Alfa Wassermann has agreement with Ligand for the marketing and distribution of Ontak, Targretin and Panretin 50
Apr 15, 1999: Supplemental NDA for Alza's Doxil in refractory ovarian cancer granted priority review. 50
Mar 30, 1999: Ligand and Ferrer Entered Into agreement for Marketing and Distribution of Panretin. 50
Feb 03, 1999: Panretin receives FDA approval 50
Aug 05, 1997: Taxol Approved for Kaposi's Sarcoma 51
Appendix 52
Methodology 52
Coverage 52
Secondary Research 52
Primary Research 52
Expert Panel Validation 52
Contact Us 53
Disclaimer 53

List of Tables

Number of Products under Development for AIDS - Related Kaposi's Sarcoma, H1 2014 7
Number of Products under Development for AIDS - Related Kaposi's Sarcoma - Comparative Analysis, H1 2014 8
Number of Products under Development by Companies, H1 2014 9
Comparative Analysis by Clinical Stage Development, H1 2014 10
Comparative Analysis by Early Stage Development, H1 2014 11
Products under Development by Companies, H1 2014 12
AIDS - Related Kaposi's Sarcoma - Pipeline by Aphios Corporation, H1 2014 13
AIDS - Related Kaposi's Sarcoma - Pipeline by CytRx Corporation, H1 2014 14
AIDS - Related Kaposi's Sarcoma - Pipeline by Cannabis Science, Inc., H1 2014 15
AIDS - Related Kaposi's Sarcoma - Pipeline by Xiamen Amoytop Biotech Co., Ltd., H1 2014 16
AIDS - Related Kaposi's Sarcoma - Pipeline by Biogenomics, H1 2014 17
Assessment by Monotherapy Products, H1 2014 18
Number of Products by Stage and Target, H1 2014 20
Number of Products by Stage and Mechanism of Action, H1 2014 22
Number of Products by Stage and Route of Administration, H1 2014 24
Number of Products by Stage and Molecule Type, H1 2014 26
Number of Products by Stage and Therapeutic Class, H1 2014 28
AIDS - Related Kaposi's Sarcoma Therapeutics - Recent Pipeline Updates, H1 2014 36
AIDS - Related Kaposi's Sarcoma - Dormant Projects, H1 2014 46
AIDS - Related Kaposi's Sarcoma - Discontinued Products, H1 2014 47

List of Figures

Number of Products under Development for AIDS - Related Kaposi's Sarcoma, H1 2014 7
Number of Products under Development for AIDS - Related Kaposi's Sarcoma - Comparative Analysis, H1 2014 8
Number of Products under Development by Companies, H1 2014 9
Assessment by Monotherapy Products, H1 2014 18
Number of Products by Top 10 Target, H1 2014 19
Number of Products by Stage and Top 10 Target, H1 2014 20
Number of Products by Top 10 Mechanism of Action, H1 2014 21
Number of Products by Stage and Top 10 Mechanism of Action, H1 2014 22
Number of Products by Top 10 Route of Administration, H1 2014 23
Number of Products by Stage and Top 10 Route of Administration, H1 2014 24
Number of Products by Top 10 Molecule Type, H1 2014 25
Number of Products by Stage and Top 10 Molecule Type, H1 2014 26
Number of Products by Top 10 Therapeutic Class, H1 2014 27
Number of Products by Stage and Top 10 Therapeutic Class, H1 2014 28

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
AIDS Related Kaposi%s Sarcoma-Market Insights, Epidemiology and Market Forecast-2023 

AIDS Related Kaposi%s Sarcoma-Market Insights, Epidemiology and Market Forecast-2023 

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s AIDS Related Kaposi’s Sarcoma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the ...

AIDS Related Kaposi%s Sarcoma - Epidemiology Forecast To 2023

AIDS Related Kaposi%s Sarcoma - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “AIDS Related Kaposi's Sarcoma - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of AIDS Related Kaposi's Sarcoma in seven major markets (US, France, Germany, ...

AIDS - Related Kaposi%s Sarcoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

AIDS - Related Kaposi%s Sarcoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “AIDS - Related Kaposi's Sarcoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...


Download Unlimited Documents from Trusted Public Sources

HIV AIDS Statistics and Cancer Statistics in India and the US

  • February 2017
    106 pages
  • HIV AIDS  

    Blood Disease  

    Cancer  

  • India  

    United States  

View report >

Cancer Statistics in the US

  • January 2017
    19 pages
  • Cancer  

  • United States  

View report >

Prostate Cancer Statistics in the US

  • January 2017
    7 pages
  • Prostate Cancer  

    Hospital  

  • United States  

View report >

Related Market Segments :

HIV AIDS
Therapy
Chemotherapy
Clinical Trial

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.